Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update
Rhea-AI Summary
Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company, has announced it will report financial results and provide a business update for its third quarter ended August 31, 2024, on Thursday, October 10 at 8:30 a.m. ET. The conference call will be hosted by Paul Lévesque, President and CEO, joined by other management team members including Philippe Dubuc, Christian Marsolais, and John Leasure.
Participants are encouraged to join the call at least ten minutes in advance. The webcast link and dial-in information have been provided. A replay of the call will be available until October 17, 2024, with toll-free and international dial-in numbers provided. An archived webcast will also be available on the Company's Investor Relations website under 'Past Events'.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, THTX gained 0.85%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
MONTREAL, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report financial results and provide a business update for its third quarter ended August 31, 2024, on Thursday, October 10 at 8:30 a.m. ET.
The call will be hosted by Paul Lévesque, President and Chief Executive Officer. He will be joined by other members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer and John Leasure, Global Commercial Officer who will be available to answer questions from participants following prepared remarks.
Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information can be found below.
| CONFERENCE CALL INFORMATION | |
| Conference Call Date | October 10, 2024 |
| Conference Call Time | 8:30 a.m. ET |
| Webcast link | https://edge.media-server.com/mmc/p/vy4y3hwc |
| Dial in | 1-888-513-4119 (toll free) or 1-412-902-6615 (international) |
| Access Code | 5313857 |
| CONFERENCE CALL REPLAY | |
| Toll Free | 1-877-344-7529 (US) / 1-855-669-9658 (Canada) |
| International Toll | 1-412-317-0088 |
| Replay Access Code | 2159194 |
| Replay End Date | October 17, 2024 |
| To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html | |
An archived webcast will also be available on the Company’s Investor Relations website under ‘Past Events’.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).
Contacts:
Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
438-315-6608
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
When will Theratechnologies (THTX) report its Q3 2024 financial results?
Who will host the Q3 2024 earnings call for Theratechnologies (THTX)?
How can investors access the Q3 2024 earnings call for Theratechnologies (THTX)?
Until what date will the replay of Theratechnologies' (THTX) Q3 2024 earnings call be available?
